Physician profile

Aaron Satran

Cardiovascular Disease · Louisville, KY

NPI 1982689618

$688.27

in general payments reported to CMS, 2019-2025

6 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$295.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $267.55 2021-2023 Perclose Prostyle
Medtronic, INC. $192.18 2021-2023 Paceart System Ecg Module
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $100.29 2019
Novartis Pharmaceuticals Corporation $79.62 2022-2024
Baxter Healthcare $30.84 2024 Hillrom - Carnation Ambulatory Monitor
E.R. Squibb & Sons, L.L.C. $17.79 2023 Eliquis

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Aaron Satran

$688.27

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbott Laboratories

https://glasscript.com/doctor/362929/aaron-satran

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.